Epidemiology of atrial fibrillation: European perspective
In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and...
Saved in:
Published in | Clinical epidemiology Vol. 6; no. default; pp. 213 - 220 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
New Zealand
Dove Medical Press Limited
01.01.2014
Taylor & Francis Ltd Dove Medical Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and the improved ability to suspect and diagnose AF. At the present time, the prevalence of AF (2%) is double that reported in the last decade. The prevalence of AF varies with age and sex. AF is present in 0.12%-0.16% of those younger than 49 years, in 3.7%-4.2% of those aged 60-70 years, and in 10%-17% of those aged 80 years or older. In addition, it occurs more frequently in males, with a male to female ratio of 1.2:1. The incidence of AF ranges between 0.21 and 0.41 per 1,000 person/years. Permanent AF occurs in approximately 50% of patients, and paroxysmal and persistent AF in 25% each. AF is frequently associated with cardiac disease and comorbidities. The most common concomitant diseases are coronary artery disease, valvular heart disease, and cardiomyopathy. The most common comorbidities are hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, renal failure, stroke, and cognitive disturbance. Paroxysmal AF occurs in younger patients and with a reduced burden of both cardiac disease and comorbidities. Generally, the history of AF is long, burdened by frequent recurrences, and associated with symptoms (in two thirds of patients). Patients with AF have a five-fold and two-fold higher risk of stroke and death, respectively. We estimate that the number of patients with AF in 2030 in Europe will be 14-17 million and the number of new cases of AF per year at 120,000-215,000. Given that AF is associated with significant morbidity and mortality, this increasing number of individuals with AF will have major public health implications. |
---|---|
AbstractList | In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and the improved ability to suspect and diagnose AF. At the present time, the prevalence of AF (2%) is double that reported in the last decade. The prevalence of AF varies with age and sex. AF is present in 0.12%–0.16% of those younger than 49 years, in 3.7%–4.2% of those aged 60–70 years, and in 10%–17% of those aged 80 years or older. In addition, it occurs more frequently in males, with a male to female ratio of 1.2:1. The incidence of AF ranges between 0.21 and 0.41 per 1,000 person/years. Permanent AF occurs in approximately 50% of patients, and paroxysmal and persistent AF in 25% each. AF is frequently associated with cardiac disease and comorbidities. The most common concomitant diseases are coronary artery disease, valvular heart disease, and cardiomyopathy. The most common comorbidities are hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, renal failure, stroke, and cognitive disturbance. Paroxysmal AF occurs in younger patients and with a reduced burden of both cardiac disease and comorbidities. Generally, the history of AF is long, burdened by frequent recurrences, and associated with symptoms (in two thirds of patients). Patients with AF have a five-fold and two-fold higher risk of stroke and death, respectively. We estimate that the number of patients with AF in 2030 in Europe will be 14–17 million and the number of new cases of AF per year at 120,000–215,000. Given that AF is associated with significant morbidity and mortality, this increasing number of individuals with AF will have major public health implications. In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and the improved ability to suspect and diagnose AF. At the present time, the prevalence of AF (2%) is double that reported in the last decade. The prevalence of AF varies with age and sex. AF is present in 0.12%-0.16% of those younger than 49 years, in 3.7%-4.2% of those aged 60-70 years, and in 10%-17% of those aged 80 years or older. In addition, it occurs more frequently in males, with a male to female ratio of 1.2:1. The incidence of AF ranges between 0.21 and 0.41 per 1,000 person/years. Permanent AF occurs in approximately 50% of patients, and paroxysmal and persistent AF in 25% each. AF is frequently associated with cardiac disease and comorbidities. The most common concomitant diseases are coronary artery disease, valvular heart disease, and cardiomyopathy. The most common comorbidities are hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, renal failure, stroke, and cognitive disturbance. Paroxysmal AF occurs in younger patients and with a reduced burden of both cardiac disease and comorbidities. Generally, the history of AF is long, burdened by frequent recurrences, and associated with symptoms (in two thirds of patients). Patients with AF have a five-fold and two-fold higher risk of stroke and death, respectively. We estimate that the number of patients with AF in 2030 in Europe will be 14-17 million and the number of new cases of AF per year at 120,000-215,000. Given that AF is associated with significant morbidity and mortality, this increasing number of individuals with AF will have major public health implications. Keywords: atrial fibrillation, epidemiology, risk factors, mortality, stroke Massimo Zoni-Berisso, Fabrizio Lercari, Tiziana Carazza, Stefano DomenicucciDepartment of Cardiology, ASL 3, Padre A Micone Hospital, Genoa, ItalyAbstract: In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and the improved ability to suspect and diagnose AF. At the present time, the prevalence of AF (2%) is double that reported in the last decade. The prevalence of AF varies with age and sex. AF is present in 0.12%-0.16% of those younger than 49 years, in 3.7%-4.2% of those aged 60-70 years, and in 10%-17% of those aged 80 years or older. In addition, it occurs more frequently in males, with a male to female ratio of 1.2:1. The incidence of AF ranges between 0.21 and 0.41 per 1,000 person/years. Permanent AF occurs in approximately 50% of patients, and paroxysmal and persistent AF in 25% each. AF is frequently associated with cardiac disease and comorbidities. The most common concomitant diseases are coronary artery disease, valvular heart disease, and cardiomyopathy. The most common comorbidities are hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, renal failure, stroke, and cognitive disturbance. Paroxysmal AF occurs in younger patients and with a reduced burden of both cardiac disease and comorbidities. Generally, the history of AF is long, burdened by frequent recurrences, and associated with symptoms (in two thirds of patients). Patients with AF have a five-fold and two-fold higher risk of stroke and death, respectively. We estimate that the number of patients with AF in 2030 in Europe will be 14-17 million and the number of new cases of AF per year at 120,000-215,000. Given that AF is associated with significant morbidity and mortality, this increasing number of individuals with AF will have major public health implications.Keywords: atrial fibrillation, epidemiology, risk factors, mortality, stroke In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and the improved ability to suspect and diagnose AF. At the present time, the prevalence of AF (2%) is double that reported in the last decade. The prevalence of AF varies with age and sex. AF is present in 0.12%-0.16% of those younger than 49 years, in 3.7%-4.2% of those aged 60-70 years, and in 10%-17% of those aged 80 years or older. In addition, it occurs more frequently in males, with a male to female ratio of 1.2:1. The incidence of AF ranges between 0.21 and 0.41 per 1,000 person/years. Permanent AF occurs in approximately 50% of patients, and paroxysmal and persistent AF in 25% each. AF is frequently associated with cardiac disease and comorbidities. The most common concomitant diseases are coronary artery disease, valvular heart disease, and cardiomyopathy. The most common comorbidities are hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, renal failure, stroke, and cognitive disturbance. Paroxysmal AF occurs in younger patients and with a reduced burden of both cardiac disease and comorbidities. Generally, the history of AF is long, burdened by frequent recurrences, and associated with symptoms (in two thirds of patients). Patients with AF have a five-fold and two-fold higher risk of stroke and death, respectively. We estimate that the number of patients with AF in 2030 in Europe will be 14-17 million and the number of new cases of AF per year at 120,000-215,000. Given that AF is associated with significant morbidity and mortality, this increasing number of individuals with AF will have major public health implications.In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and the improved ability to suspect and diagnose AF. At the present time, the prevalence of AF (2%) is double that reported in the last decade. The prevalence of AF varies with age and sex. AF is present in 0.12%-0.16% of those younger than 49 years, in 3.7%-4.2% of those aged 60-70 years, and in 10%-17% of those aged 80 years or older. In addition, it occurs more frequently in males, with a male to female ratio of 1.2:1. The incidence of AF ranges between 0.21 and 0.41 per 1,000 person/years. Permanent AF occurs in approximately 50% of patients, and paroxysmal and persistent AF in 25% each. AF is frequently associated with cardiac disease and comorbidities. The most common concomitant diseases are coronary artery disease, valvular heart disease, and cardiomyopathy. The most common comorbidities are hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, renal failure, stroke, and cognitive disturbance. Paroxysmal AF occurs in younger patients and with a reduced burden of both cardiac disease and comorbidities. Generally, the history of AF is long, burdened by frequent recurrences, and associated with symptoms (in two thirds of patients). Patients with AF have a five-fold and two-fold higher risk of stroke and death, respectively. We estimate that the number of patients with AF in 2030 in Europe will be 14-17 million and the number of new cases of AF per year at 120,000-215,000. Given that AF is associated with significant morbidity and mortality, this increasing number of individuals with AF will have major public health implications. |
Audience | Academic |
Author | Zoni-Berisso, Massimo Carazza, Tiziana Lercari, Fabrizio Domenicucci, Stefano |
AuthorAffiliation | Department of Cardiology, ASL 3, Padre A Micone Hospital, Genoa, Italy |
AuthorAffiliation_xml | – name: Department of Cardiology, ASL 3, Padre A Micone Hospital, Genoa, Italy |
Author_xml | – sequence: 1 givenname: Massimo surname: Zoni-Berisso fullname: Zoni-Berisso, Massimo – sequence: 2 givenname: Fabrizio surname: Lercari fullname: Lercari, Fabrizio – sequence: 3 givenname: Tiziana surname: Carazza fullname: Carazza, Tiziana – sequence: 4 givenname: Stefano surname: Domenicucci fullname: Domenicucci, Stefano |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24966695$$D View this record in MEDLINE/PubMed |
BookMark | eNptkt9r2zAQx8XoWLuuT3sfhsEYlGT6aVt7GJSQboXABtuehSxLiYJieZJd6H-_c9OWpNR6sH363Peku-9bdNLFziL0nuA5Jbz6slgtf81_84rV4hU6I6SSM8K4PDn4PkUXOW8xPIyRqsJv0CnlsixLKc6QXPa-tTsfQ1zfFdEVekheh8L5JvkQ9OBj97VYjin2VndFb1PurRn8rX2HXjsdsr14eJ-jv9fLP4sfs9XP7zeLq9XMiFIOM0OxJhWWjPOKO-cIr7GGCK_hzJxa2eK2rNqqrpuaNpKWFhurMddUUqlbx87RzV63jXqr-uR3Ot2pqL26D8S0VjoN3gSrpCWucY5JDvfmJYOi8E-dsKLhtTGg9W2v1Y_NzrbGdkPS4Uj0eKfzG7WOt4rjkktBQeDzg0CK_0abB7Xz2VhoVGfjmBURULpmAgtAPz5Dt3FMHbRKUUo5h4kB-0StNVzAdy5CXTOJqiuOMRWslBM1f4GCNY3OgCOch_hRwqeDhI3VYdjkGMZpnPkY_HDYkadWPDoEALIHTIo5J-uU8cO9LeAIPiiC1WRENRlR7Y0IOZfPch5lX6L_A8jn2iw |
CitedBy_id | crossref_primary_10_35336_VA_2021_3_5_12 crossref_primary_10_1111_bcp_14221 crossref_primary_10_15407_internalmed2021_02_103 crossref_primary_10_1007_s10840_018_0370_y crossref_primary_10_1093_eurheartj_ehw210 crossref_primary_10_1016_j_vph_2016_03_006 crossref_primary_10_1007_s12325_024_02895_w crossref_primary_10_1016_j_ijcha_2019_100461 crossref_primary_10_3389_fmed_2019_00175 crossref_primary_10_1177_1708538119881077 crossref_primary_10_61189_061485jysfwu crossref_primary_10_1093_ejcts_ezw313 crossref_primary_10_3389_fcvm_2021_689313 crossref_primary_10_1111_jce_15317 crossref_primary_10_1177_03331024241254517 crossref_primary_10_1186_s12916_022_02505_y crossref_primary_10_1055_a_2337_4025 crossref_primary_10_1016_j_ejim_2024_03_014 crossref_primary_10_1016_j_ijcard_2018_11_127 crossref_primary_10_1016_j_cvdhj_2020_08_004 crossref_primary_10_1016_j_ijcard_2021_03_015 crossref_primary_10_1093_ageing_afab273 crossref_primary_10_1109_JBHI_2022_3199910 crossref_primary_10_1080_1354750X_2020_1814414 crossref_primary_10_1111_pace_13353 crossref_primary_10_1186_s12889_020_8275_y crossref_primary_10_1002_joa3_13038 crossref_primary_10_2196_48748 crossref_primary_10_1016_j_ceh_2024_03_001 crossref_primary_10_21886_2712_8156_2023_4_4_41_50 crossref_primary_10_1111_eci_13385 crossref_primary_10_1007_s00424_017_2054_3 crossref_primary_10_1186_s12864_020_06944_w crossref_primary_10_1016_j_medcli_2024_05_013 crossref_primary_10_1186_s12913_024_11100_1 crossref_primary_10_1016_j_ijcard_2021_11_008 crossref_primary_10_1155_2021_9996047 crossref_primary_10_1098_rsos_171214 crossref_primary_10_1111_echo_13899 crossref_primary_10_1136_bmj_n379 crossref_primary_10_1161_JAHA_124_036832 crossref_primary_10_1590_0004_282x20200105 crossref_primary_10_1016_j_ejphar_2017_03_039 crossref_primary_10_5551_jat_63574 crossref_primary_10_1161_CIRCEP_118_006242 crossref_primary_10_1002_mds_29596 crossref_primary_10_1186_s43044_022_00291_9 crossref_primary_10_1371_journal_pone_0226730 crossref_primary_10_1111_pace_14697 crossref_primary_10_1253_circrep_CR_20_0139 crossref_primary_10_17116_kardio202013061530 crossref_primary_10_1186_s12872_019_1105_4 crossref_primary_10_1016_j_dld_2021_11_011 crossref_primary_10_1111_ene_13538 crossref_primary_10_5301_GTND_2017_17030 crossref_primary_10_1001_jamanetworkopen_2021_40071 crossref_primary_10_1016_j_amjcard_2014_12_003 crossref_primary_10_1109_TMI_2019_2946345 crossref_primary_10_36660_abc_20201003 crossref_primary_10_1016_j_cmpb_2019_05_028 crossref_primary_10_1093_europace_euac144 crossref_primary_10_3109_15412555_2015_1043425 crossref_primary_10_35336_VA_1309 crossref_primary_10_1016_j_amjcard_2020_03_050 crossref_primary_10_1007_s10557_020_07103_9 crossref_primary_10_17925_EJAE_2018_4_2_56 crossref_primary_10_1002_clc_23452 crossref_primary_10_1016_j_artres_2018_05_004 crossref_primary_10_1097_FJC_0000000000000338 crossref_primary_10_1016_j_crvasa_2017_06_008 crossref_primary_10_1177_1074248419879089 crossref_primary_10_1016_j_sipas_2022_100153 crossref_primary_10_1093_ehjqcco_qcw031 crossref_primary_10_1111_jce_14598 crossref_primary_10_1016_j_recesp_2020_10_022 crossref_primary_10_1007_s11897_019_00430_5 crossref_primary_10_1093_ageing_afad216 crossref_primary_10_1093_icvts_ivy210 crossref_primary_10_1002_hon_2655 crossref_primary_10_1136_bmjopen_2019_033712 crossref_primary_10_1016_j_ahj_2019_04_015 crossref_primary_10_1093_ehjcvp_pvz016 crossref_primary_10_1016_j_blre_2019_03_005 crossref_primary_10_1016_j_breast_2019_05_017 crossref_primary_10_1016_j_clinsp_2022_100014 crossref_primary_10_1093_eurheartj_ehz834 crossref_primary_10_1038_s41569_020_00459_3 crossref_primary_10_3389_fcvm_2020_615927 crossref_primary_10_1113_EP086589 crossref_primary_10_1002_cre2_70041 crossref_primary_10_1007_s12350_023_03248_w crossref_primary_10_2217_fca_15_31 crossref_primary_10_1177_2047487315624524 crossref_primary_10_1016_j_camwa_2017_05_012 crossref_primary_10_1186_s12875_017_0588_2 crossref_primary_10_1136_openhrt_2023_002563 crossref_primary_10_1002_clc_23329 crossref_primary_10_1097_MS9_0000000000001605 crossref_primary_10_3892_mmr_2017_6477 crossref_primary_10_1109_JIOT_2022_3188771 crossref_primary_10_1080_14017431_2018_1546892 crossref_primary_10_1136_heartjnl_2020_317612 crossref_primary_10_61186_hsm_3_4_348 crossref_primary_10_1177_0037549718782401 crossref_primary_10_1007_s11239_018_1634_1 crossref_primary_10_1186_s12913_019_4372_y crossref_primary_10_1016_j_arr_2021_101527 crossref_primary_10_1016_j_ultrasmedbio_2018_02_004 crossref_primary_10_1186_s12889_022_12628_9 crossref_primary_10_2174_0929867326666191213095554 crossref_primary_10_1080_14779072_2018_1533118 crossref_primary_10_1016_j_cjca_2018_08_018 crossref_primary_10_1093_ehjqcco_qcad060 crossref_primary_10_1186_s13049_021_00866_6 crossref_primary_10_20996_1819_6446_2019_15_4_530_537 crossref_primary_10_3389_fphys_2020_00912 crossref_primary_10_1007_s10557_020_06971_5 crossref_primary_10_1177_1479164117735013 crossref_primary_10_1253_circrep_CR_23_0007 crossref_primary_10_1016_j_pec_2019_03_015 crossref_primary_10_1016_j_cmpb_2025_108606 crossref_primary_10_1186_s13561_022_00362_2 crossref_primary_10_1136_bmjopen_2016_013180 crossref_primary_10_1172_jci_insight_99941 crossref_primary_10_1136_bmjebm_2020_111634 crossref_primary_10_1007_s00391_022_02017_7 crossref_primary_10_1136_openhrt_2019_001165 crossref_primary_10_1080_14779072_2017_1355237 crossref_primary_10_1016_j_rxeng_2025_01_002 crossref_primary_10_1186_s13019_023_02189_2 crossref_primary_10_1007_s00380_022_02101_3 crossref_primary_10_1161_JAHA_119_013053 crossref_primary_10_1016_j_compbiomed_2019_103540 crossref_primary_10_1093_eurjcn_zvae164 crossref_primary_10_29045_14784726_2022_06_7_1_51 crossref_primary_10_1007_s12471_020_01528_5 crossref_primary_10_1093_ehjcvp_pvy026 crossref_primary_10_1161_CIRCRESAHA_119_315686 crossref_primary_10_1016_j_jcct_2018_06_005 crossref_primary_10_1007_s12928_024_00984_9 crossref_primary_10_1016_j_nrl_2021_06_004 crossref_primary_10_3389_fcvm_2021_720129 crossref_primary_10_1253_circj_CJ_19_0974 crossref_primary_10_1161_JAHA_117_006057 crossref_primary_10_1088_1361_6579_ab2cb8 crossref_primary_10_1136_jech_2019_212720 crossref_primary_10_1016_j_jtha_2024_07_011 crossref_primary_10_1136_openhrt_2023_002544 crossref_primary_10_1080_22423982_2024_2311965 crossref_primary_10_23736_S2724_5683_24_06464_0 crossref_primary_10_23950_1812_2892_JCMK_00542 crossref_primary_10_1016_j_hrthm_2020_09_017 crossref_primary_10_1016_j_ijcha_2020_100709 crossref_primary_10_1111_pace_14413 crossref_primary_10_31083_j_rcm2307242 crossref_primary_10_1016_j_ccep_2019_11_003 crossref_primary_10_1016_j_ijcard_2018_03_063 crossref_primary_10_1186_s13102_024_01000_6 crossref_primary_10_1016_j_hroo_2021_09_004 crossref_primary_10_1371_journal_pmed_1003197 crossref_primary_10_1007_s10554_021_02331_y crossref_primary_10_1093_eurheartj_ehy778 crossref_primary_10_1016_j_jpsychores_2023_111542 crossref_primary_10_1097_XEB_0000000000000190 crossref_primary_10_20538_1682_0363_2019_4_209_221 crossref_primary_10_5507_bp_2018_083 crossref_primary_10_1136_openhrt_2019_001026 crossref_primary_10_1080_17425255_2017_1258054 crossref_primary_10_7759_cureus_16027 crossref_primary_10_1016_j_amjcard_2019_05_040 crossref_primary_10_3389_fcvm_2023_1207064 crossref_primary_10_1016_j_ajmo_2022_100026 crossref_primary_10_1186_s13049_017_0424_7 crossref_primary_10_1016_j_jtcvs_2019_10_186 crossref_primary_10_1016_j_bbrc_2019_03_074 crossref_primary_10_1016_j_diii_2021_05_010 crossref_primary_10_1016_j_medcle_2024_05_010 crossref_primary_10_1007_s12181_017_0206_5 crossref_primary_10_1016_j_thromres_2022_03_011 crossref_primary_10_1093_ehjqcco_qcy015 crossref_primary_10_1007_s10840_020_00709_x crossref_primary_10_1007_s11239_020_02194_5 crossref_primary_10_1016_j_compbiomed_2019_103444 crossref_primary_10_15420_aer_2021_01 crossref_primary_10_1093_europace_euw211 crossref_primary_10_1155_2022_9295326 crossref_primary_10_1177_1076029620910808 crossref_primary_10_1016_j_ijcha_2022_101130 crossref_primary_10_5812_mca_141645 crossref_primary_10_3892_mmr_2018_9124 crossref_primary_10_1016_j_ijcard_2017_02_074 crossref_primary_10_1016_j_jmh_2025_100306 crossref_primary_10_1002_clc_24335 crossref_primary_10_1007_s00380_023_02278_1 crossref_primary_10_1016_j_vhri_2019_05_004 crossref_primary_10_1038_jhh_2017_23 crossref_primary_10_1371_journal_pone_0259652 crossref_primary_10_2196_24461 crossref_primary_10_1016_j_ijcard_2023_131595 crossref_primary_10_1182_bloodadvances_2017015461 crossref_primary_10_1080_14740338_2019_1676723 crossref_primary_10_1016_j_hrcr_2024_04_011 crossref_primary_10_1016_j_jstrokecerebrovasdis_2016_05_030 crossref_primary_10_1371_journal_pone_0269867 crossref_primary_10_1161_STROKEAHA_115_011476 crossref_primary_10_24835_1607_0763_2018_3_33_48 crossref_primary_10_7243_2053_7662_4_8 crossref_primary_10_33590_emjcardiol_10310415 crossref_primary_10_1016_j_ijcha_2022_100991 crossref_primary_10_1016_j_maturitas_2020_10_012 crossref_primary_10_1007_s00228_017_2296_1 crossref_primary_10_1093_europace_euaa261 crossref_primary_10_23736_S0026_4806_18_05824_X crossref_primary_10_1097_MD_0000000000014549 crossref_primary_10_1093_ehjcvp_pvaa018 crossref_primary_10_1016_j_bbamcr_2022_119365 crossref_primary_10_1002_pdi_2155 crossref_primary_10_1016_j_ajem_2020_09_046 crossref_primary_10_1016_j_bspc_2019_101819 crossref_primary_10_3904_kjim_2015_224 crossref_primary_10_1002_clc_24240 crossref_primary_10_1016_j_medcli_2021_01_003 crossref_primary_10_1016_j_pjnns_2017_07_005 crossref_primary_10_1016_j_medcle_2021_01_010 crossref_primary_10_1111_jch_13931 crossref_primary_10_1186_s13020_023_00812_x crossref_primary_10_1016_j_jaccao_2021_05_004 crossref_primary_10_1016_j_cmpb_2020_105753 crossref_primary_10_1016_j_amjcard_2015_04_013 crossref_primary_10_1016_j_ihj_2016_06_006 crossref_primary_10_1016_S1636_5410_19_42595_6 crossref_primary_10_1016_j_recesp_2017_01_027 crossref_primary_10_1093_ejendo_lvae117 crossref_primary_10_1016_j_socscimed_2024_116944 crossref_primary_10_1016_j_jjcc_2018_02_018 crossref_primary_10_1097_HJH_0000000000001731 crossref_primary_10_1016_j_poamed_2016_03_003 crossref_primary_10_7759_cureus_47278 crossref_primary_10_1097_MD_0000000000014544 crossref_primary_10_1038_s41598_024_60298_x crossref_primary_10_1007_s10877_020_00458_2 crossref_primary_10_1016_j_mhp_2022_200245 crossref_primary_10_1016_j_jacl_2019_12_002 crossref_primary_10_1177_2333721419859687 crossref_primary_10_1007_s10840_023_01680_z crossref_primary_10_1515_rrlm_2017_0041 crossref_primary_10_2147_IJGM_S366956 crossref_primary_10_1016_j_hjc_2020_11_007 crossref_primary_10_1016_j_ijcard_2023_04_007 crossref_primary_10_1016_j_ijcard_2023_131445 crossref_primary_10_1080_07853890_2022_2117407 crossref_primary_10_1007_s00392_019_01418_w crossref_primary_10_2478_rjdnmd_2018_0019 crossref_primary_10_1055_s_0041_1726331 crossref_primary_10_3109_14017431_2015_1103892 crossref_primary_10_1016_j_isci_2024_109609 crossref_primary_10_36660_abc_20230680 crossref_primary_10_1016_j_ijcard_2020_08_097 crossref_primary_10_1080_13543784_2021_1897786 crossref_primary_10_1016_j_clnu_2020_06_003 crossref_primary_10_1016_j_hrthm_2018_08_012 crossref_primary_10_1016_j_ejmg_2022_104459 crossref_primary_10_1053_j_jvca_2021_02_050 crossref_primary_10_1177_2047487319861226 crossref_primary_10_1016_j_hrthm_2015_12_030 crossref_primary_10_3389_fcvm_2023_1060030 crossref_primary_10_1161_JAHA_119_014287 crossref_primary_10_3389_fphys_2023_1209458 crossref_primary_10_1253_circj_CJ_20_0883 crossref_primary_10_1093_eurheartj_ehaa612 crossref_primary_10_1177_1074248420930136 crossref_primary_10_1016_j_ypmed_2023_107584 crossref_primary_10_1111_jocn_14373 crossref_primary_10_1016_j_ejim_2016_04_007 crossref_primary_10_1093_europace_euv202 crossref_primary_10_1038_s41598_017_04604_w crossref_primary_10_1253_circj_CJ_17_0519 crossref_primary_10_1016_j_acvd_2016_08_001 crossref_primary_10_1136_heartjnl_2018_313350 crossref_primary_10_1080_00365521_2017_1410568 crossref_primary_10_3389_fcvm_2022_847163 crossref_primary_10_1136_bmjopen_2015_010745 crossref_primary_10_1093_europace_euaa139 crossref_primary_10_1111_anec_13059 crossref_primary_10_1109_OJEMB_2024_3401105 crossref_primary_10_2196_21436 crossref_primary_10_1016_j_heliyon_2023_e12887 crossref_primary_10_33667_2078_5631_2019_4_35_410__5_8 crossref_primary_10_29169_1927_5951_2019_09_02_6 crossref_primary_10_1136_bmjopen_2020_040054 crossref_primary_10_1159_000507046 crossref_primary_10_26442_00403660_2022_09_201891 crossref_primary_10_1016_j_rx_2023_06_008 crossref_primary_10_3389_fphar_2021_638445 crossref_primary_10_1002_14651858_CD014819 crossref_primary_10_1016_j_xjse_2024_100006 crossref_primary_10_1186_s12872_022_02865_6 crossref_primary_10_1016_j_compbiomed_2023_106719 crossref_primary_10_1016_j_mad_2020_111326 crossref_primary_10_1007_s11096_020_01025_0 crossref_primary_10_1016_j_tcm_2022_04_002 crossref_primary_10_33678_cor_2019_023 crossref_primary_10_1016_j_crphys_2021_12_001 crossref_primary_10_1097_MD_0000000000037750 crossref_primary_10_1136_heartjnl_2021_319120 crossref_primary_10_1111_bcp_14938 crossref_primary_10_1007_s11265_020_01531_4 crossref_primary_10_2174_1389200219666181011160133 crossref_primary_10_1161_CIRCEP_120_009288 crossref_primary_10_1097_CRD_0000000000000479 crossref_primary_10_1371_journal_pone_0125161 crossref_primary_10_2459_JCM_0000000000000236 crossref_primary_10_7861_clinmedicine_16_3_272 crossref_primary_10_1007_s00101_017_0334_0 crossref_primary_10_1007_s12551_020_00735_z crossref_primary_10_1111_jce_16399 crossref_primary_10_1016_j_acvd_2019_02_003 crossref_primary_10_1159_000539289 crossref_primary_10_34921_amj_2023_2_024 crossref_primary_10_2217_cer_2019_0125 crossref_primary_10_1093_inthealth_ihy075 crossref_primary_10_6000_1929_6029_2023_12_06 crossref_primary_10_1002_pds_4192 crossref_primary_10_11124_JBIES_20_00168 crossref_primary_10_1177_1753944715605011 crossref_primary_10_1016_j_atherosclerosis_2020_08_026 crossref_primary_10_3389_fsurg_2024_1404450 crossref_primary_10_1016_j_lanepe_2024_101134 crossref_primary_10_1007_s11548_018_1874_8 crossref_primary_10_1038_s41598_019_40445_5 crossref_primary_10_2174_1381612826666200407150307 crossref_primary_10_1016_j_repce_2016_12_020 crossref_primary_10_1080_15421406_2017_1360572 crossref_primary_10_1371_journal_pone_0259916 crossref_primary_10_1111_imj_16101 crossref_primary_10_1016_j_jchf_2019_03_005 crossref_primary_10_1016_j_arcmed_2019_05_007 crossref_primary_10_1097_CRD_0000000000000493 crossref_primary_10_1002_joa3_12608 crossref_primary_10_1177_23969873211008770 crossref_primary_10_1002_jcsm_13401 crossref_primary_10_7759_cureus_25252 crossref_primary_10_2196_23425 crossref_primary_10_1016_j_jval_2016_07_007 crossref_primary_10_1016_j_ahj_2016_05_014 crossref_primary_10_1093_icvts_ivx446 crossref_primary_10_1259_bjr_20211274 crossref_primary_10_1186_s10020_025_01162_0 crossref_primary_10_3389_fcell_2024_1298007 crossref_primary_10_1213_ANE_0000000000002070 crossref_primary_10_1536_ihj_20_238 crossref_primary_10_1007_s10654_017_0283_6 crossref_primary_10_1097_HCO_0000000000000245 crossref_primary_10_1007_s12325_020_01307_z crossref_primary_10_1016_j_amjcard_2021_12_039 crossref_primary_10_1016_j_amjcard_2016_06_009 crossref_primary_10_1016_j_ahj_2020_02_016 crossref_primary_10_1038_s41371_019_0279_7 crossref_primary_10_1093_ehjqcco_qcac023 crossref_primary_10_1146_annurev_physiol_021317_121454 crossref_primary_10_1056_NEJMc1409495 crossref_primary_10_1007_s12551_017_0255_9 crossref_primary_10_1177_2048872618758931 crossref_primary_10_1007_s00740_018_0217_2 crossref_primary_10_1186_s12872_024_04215_0 crossref_primary_10_1007_s40520_019_01152_3 crossref_primary_10_1111_jocs_15844 crossref_primary_10_1016_j_amjmed_2020_08_026 crossref_primary_10_1016_j_hroo_2024_12_006 crossref_primary_10_1097_MD_0000000000028797 crossref_primary_10_1007_s00134_019_05633_x crossref_primary_10_1111_jce_13936 crossref_primary_10_1586_14779072_2015_1026259 crossref_primary_10_1097_MJT_0000000000000590 crossref_primary_10_1111_eci_13952 crossref_primary_10_1111_imj_13777 crossref_primary_10_1097_01_JAA_0000944600_04370_48 crossref_primary_10_1016_j_hlc_2019_05_185 crossref_primary_10_1093_europace_euaa421 crossref_primary_10_23736_S2724_5683_22_05841_0 crossref_primary_10_1007_s10840_019_00603_1 crossref_primary_10_1093_eurheartj_suaa176 crossref_primary_10_1016_j_ajem_2023_05_041 crossref_primary_10_1093_eurheartj_suaa179 crossref_primary_10_54359_ps_v14i76_137 crossref_primary_10_1016_j_cellsig_2022_110475 crossref_primary_10_35366_94772 crossref_primary_10_1016_j_ijcard_2015_11_084 crossref_primary_10_1016_j_jelectrocard_2019_12_009 crossref_primary_10_22141_2224_0586_17_4_2021_237735 crossref_primary_10_3389_fneur_2023_1269651 crossref_primary_10_1016_j_ccep_2020_10_002 crossref_primary_10_1177_23247096211010048 crossref_primary_10_1111_jch_14848 crossref_primary_10_1109_TSP_2020_3006766 crossref_primary_10_1016_j_cardfail_2024_05_017 crossref_primary_10_1080_17434440_2022_2141112 crossref_primary_10_1093_eurheartj_suv037 crossref_primary_10_1097_MJT_0000000000000344 crossref_primary_10_1128_mSphere_00071_20 crossref_primary_10_1161_JAHA_118_009024 crossref_primary_10_1016_j_jaccas_2020_02_027 crossref_primary_10_1080_14737167_2021_1979961 crossref_primary_10_1080_13696998_2020_1752220 crossref_primary_10_1253_circj_CJ_21_0180 crossref_primary_10_1016_j_jacc_2016_06_062 crossref_primary_10_1016_j_yjmcc_2014_12_005 crossref_primary_10_1016_j_fitote_2019_104272 crossref_primary_10_3389_fphys_2019_01138 crossref_primary_10_1016_j_cpcardiol_2023_102024 crossref_primary_10_1007_s40266_020_00771_0 crossref_primary_10_1016_j_thromres_2016_04_022 crossref_primary_10_3389_fgene_2022_1003366 crossref_primary_10_1016_j_cmpb_2019_105219 crossref_primary_10_1016_j_ienj_2017_03_006 crossref_primary_10_1016_j_bspc_2020_102194 crossref_primary_10_1093_icvts_ivab322 crossref_primary_10_1002_vrc2_1031 crossref_primary_10_1136_ebnurs_2019_103151 crossref_primary_10_1111_ijcp_14042 crossref_primary_10_56294_hl2023202 crossref_primary_10_1016_j_rec_2018_06_027 crossref_primary_10_1093_fampra_cmab057 crossref_primary_10_1111_jch_13755 crossref_primary_10_1007_s12410_019_9520_6 crossref_primary_10_3389_fphar_2018_01005 crossref_primary_10_1080_07853890_2024_2423789 crossref_primary_10_1093_rheumatology_kead336 crossref_primary_10_1016_j_jacasi_2021_10_009 crossref_primary_10_17116_terarkh2017899120_127 crossref_primary_10_1016_j_amjcard_2023_11_009 crossref_primary_10_1016_j_gene_2015_08_062 crossref_primary_10_1111_1753_0407_13432 crossref_primary_10_1016_j_nrleng_2021_06_005 crossref_primary_10_17802_2306_1278_2018_7_3_12_23 crossref_primary_10_1002_ehf2_14607 crossref_primary_10_1016_j_hrthm_2024_04_012 crossref_primary_10_1177_03000605211057822 crossref_primary_10_1177_2047487318777387 crossref_primary_10_1016_j_mad_2017_09_002 crossref_primary_10_22328_2413_5747_2019_5_3_7_16 crossref_primary_10_1038_s41684_023_01141_0 crossref_primary_10_1016_j_jelectrocard_2019_04_010 crossref_primary_10_15829_1560_4071_2018_11_96_99 crossref_primary_10_1016_j_heliyon_2024_e25295 crossref_primary_10_1088_1361_6579_aae304 crossref_primary_10_1186_s40248_015_0023_2 crossref_primary_10_1016_j_mehy_2014_11_012 crossref_primary_10_1016_j_med_2017_07_010 crossref_primary_10_1136_eb_2017_102741 crossref_primary_10_2217_cer_2019_0070 crossref_primary_10_1016_j_cjco_2021_09_006 crossref_primary_10_1093_europace_euy160 crossref_primary_10_2459_JCM_0000000000000986 crossref_primary_10_1016_j_amjcard_2019_11_021 crossref_primary_10_1177_1753944719891688 crossref_primary_10_1080_17434440_2022_2096437 crossref_primary_10_1002_jppr_1715 crossref_primary_10_1016_j_ijcard_2018_07_066 crossref_primary_10_1111_joim_13393 crossref_primary_10_1093_cvr_cvac016 crossref_primary_10_7326_M21_3498 crossref_primary_10_15406_ppij_2019_07_00235 crossref_primary_10_1016_j_ahj_2016_03_001 crossref_primary_10_3389_fcvm_2023_1067964 crossref_primary_10_1097_MD_0000000000003102 crossref_primary_10_32415_jscientia_2019_07_02 crossref_primary_10_1088_1361_6579_aad9f0 crossref_primary_10_1177_1049732320951772 crossref_primary_10_1161_STROKEAHA_115_009487 crossref_primary_10_54359_ps_v13i74_161 crossref_primary_10_1186_s12933_021_01318_2 crossref_primary_10_1016_j_knosys_2020_106589 crossref_primary_10_2217_cer_2019_0089 crossref_primary_10_1080_14779072_2020_1734452 crossref_primary_10_1111_jce_14930 crossref_primary_10_1186_s13195_019_0496_x crossref_primary_10_1007_s12603_020_1507_0 crossref_primary_10_1016_j_hroo_2022_07_008 crossref_primary_10_15212_CVIA_2016_0060 crossref_primary_10_1016_j_ijmedinf_2022_104790 crossref_primary_10_1016_j_ijrobp_2020_10_036 crossref_primary_10_1016_j_repce_2014_08_006 crossref_primary_10_1111_dom_14243 crossref_primary_10_36660_abc_20230680i crossref_primary_10_1177_1076029615619485 crossref_primary_10_1016_j_ijcard_2018_07_051 crossref_primary_10_1124_jpet_116_234591 crossref_primary_10_1016_j_mayocp_2021_12_018 crossref_primary_10_1186_s12933_019_0983_1 crossref_primary_10_1186_s12872_024_04086_5 crossref_primary_10_1080_03007995_2022_2061705 crossref_primary_10_1016_j_tet_2022_132874 crossref_primary_10_1161_STROKEAHA_115_009371 crossref_primary_10_1016_j_eswa_2018_08_011 crossref_primary_10_1016_j_bspc_2019_101563 crossref_primary_10_2478_prolas_2020_0001 crossref_primary_10_1016_j_hrthm_2024_04_064 crossref_primary_10_1016_j_emc_2020_12_001 crossref_primary_10_1016_j_jval_2017_06_005 crossref_primary_10_1111_bph_14043 crossref_primary_10_1371_journal_pone_0195175 crossref_primary_10_1016_j_ancard_2018_09_013 crossref_primary_10_1161_JAHA_123_033840 crossref_primary_10_1007_s11739_019_02151_y crossref_primary_10_1186_s40359_023_01457_z crossref_primary_10_3389_fneur_2021_721337 crossref_primary_10_1016_j_amjmed_2021_10_021 crossref_primary_10_1080_21691401_2019_1637885 crossref_primary_10_1038_s41598_024_67100_y crossref_primary_10_12968_hmed_2019_80_6_C82 crossref_primary_10_1038_s41598_021_02179_1 crossref_primary_10_1186_s12872_022_02737_z crossref_primary_10_33590_emjcardiol_10312782 crossref_primary_10_1111_jocn_14852 crossref_primary_10_1161_JAHA_118_011112 crossref_primary_10_1016_j_jacep_2024_12_007 crossref_primary_10_1016_j_jstrokecerebrovasdis_2017_01_022 crossref_primary_10_1038_s41572_022_00347_9 crossref_primary_10_7759_cureus_53093 crossref_primary_10_1007_s11606_019_05073_9 crossref_primary_10_2217_cer_15_44 crossref_primary_10_3389_fmed_2020_00414 crossref_primary_10_1080_17843286_2021_1913547 crossref_primary_10_1111_pace_15090 crossref_primary_10_1124_pr_117_014183 crossref_primary_10_15829_1560_4071_2018_12_119_124 crossref_primary_10_1016_j_rccl_2022_06_005 crossref_primary_10_1093_eurheartj_suab153 crossref_primary_10_1136_jmedgenet_2019_106676 crossref_primary_10_1098_rstb_2022_0174 crossref_primary_10_1016_j_ahj_2023_11_015 crossref_primary_10_1080_01616412_2020_1738648 crossref_primary_10_1038_s41569_019_0179_0 crossref_primary_10_1080_08820139_2021_1884091 crossref_primary_10_20514_2226_6704_2025_15_1_17_23 crossref_primary_10_1007_s10439_017_1832_6 crossref_primary_10_1093_europace_eux031 crossref_primary_10_1007_s00059_016_4423_7 crossref_primary_10_1186_s13063_021_05497_x crossref_primary_10_1016_j_jaccas_2022_101702 crossref_primary_10_1007_s41870_023_01241_7 crossref_primary_10_1007_s00392_022_02117_9 crossref_primary_10_1177_1474515118804353 crossref_primary_10_1093_europace_euae183 crossref_primary_10_1098_rsos_221620 crossref_primary_10_1016_j_eswa_2022_118540 crossref_primary_10_1016_j_repc_2016_12_011 crossref_primary_10_1080_03007995_2017_1347090 crossref_primary_10_1111_1440_1681_12863 crossref_primary_10_1093_eurheartj_ehv513 crossref_primary_10_1088_1361_6579_aac552 crossref_primary_10_1111_pace_14282 crossref_primary_10_1016_j_bbe_2015_10_004 crossref_primary_10_1093_ehjci_jeac080 crossref_primary_10_1111_liv_12928 crossref_primary_10_21518_2079_701X_2019_21_58_64 crossref_primary_10_3389_fphar_2025_1362060 crossref_primary_10_1007_s11739_023_03375_9 crossref_primary_10_1016_j_amjcard_2016_09_002 crossref_primary_10_1016_j_hjc_2017_11_017 crossref_primary_10_1016_j_jjcc_2017_07_008 crossref_primary_10_2478_jim_2020_0012 crossref_primary_10_1177_2047487317740644 crossref_primary_10_1016_j_hrthm_2019_07_026 crossref_primary_10_24884_2072_6716_2021_22_2_32_37 crossref_primary_10_1111_bcp_14171 crossref_primary_10_35336_VA_2020_1_63_69 crossref_primary_10_1007_s00399_019_0633_z crossref_primary_10_1111_jcmm_18582 crossref_primary_10_1007_s40292_019_00334_4 crossref_primary_10_1016_j_ahj_2021_08_020 crossref_primary_10_1016_j_ijcha_2022_101153 crossref_primary_10_1253_circj_CJ_19_0898 crossref_primary_10_1080_0886022X_2021_2019588 crossref_primary_10_1016_j_slast_2024_100186 crossref_primary_10_1016_j_jacep_2017_06_020 crossref_primary_10_1016_j_jstrokecerebrovasdis_2018_05_044 crossref_primary_10_1016_j_ahj_2022_09_002 crossref_primary_10_1007_s12325_021_01724_8 crossref_primary_10_1016_j_rec_2017_02_019 crossref_primary_10_1007_s10741_019_09837_7 crossref_primary_10_1007_s12603_020_1418_0 crossref_primary_10_1007_s12325_023_02544_8 crossref_primary_10_1136_bmjopen_2018_021704 crossref_primary_10_4103_heartviews_heartviews_80_22 crossref_primary_10_1016_j_comcom_2021_08_002 crossref_primary_10_1177_1474515117720326 crossref_primary_10_1016_j_jjcc_2017_12_010 crossref_primary_10_1093_europace_eux293 crossref_primary_10_2459_JCM_0000000000000962 crossref_primary_10_1016_j_repc_2014_08_005 crossref_primary_10_3389_fphys_2021_749635 crossref_primary_10_1177_0003319717722283 crossref_primary_10_1186_s12944_023_01990_1 crossref_primary_10_1097_MEJ_0000000000000402 crossref_primary_10_1080_14779072_2017_1340156 crossref_primary_10_1093_europace_euz119 crossref_primary_10_17116_kardio202114051400 crossref_primary_10_1093_europace_eux177 crossref_primary_10_3389_fphys_2018_01206 crossref_primary_10_5507_bp_2024_037 crossref_primary_10_2478_abm_2022_0016 crossref_primary_10_1016_j_ijcard_2018_02_066 crossref_primary_10_1016_j_jacbts_2019_05_005 crossref_primary_10_1016_j_cpcardiol_2024_102381 crossref_primary_10_1177_10760296211049786 crossref_primary_10_1042_CS20150586 crossref_primary_10_1161_JAHA_121_021224 crossref_primary_10_3389_fphys_2022_1030307 crossref_primary_10_1016_j_ancard_2024_101803 crossref_primary_10_24125_sanamed_v15i2_417 crossref_primary_10_3389_fcvm_2020_00067 crossref_primary_10_1007_s00059_024_05275_w crossref_primary_10_1161_CIRCEP_118_007030 crossref_primary_10_1016_j_hrthm_2021_01_018 crossref_primary_10_1111_jce_14638 crossref_primary_10_1111_nyas_14332 crossref_primary_10_3892_ijmm_2019_4063 crossref_primary_10_4254_wjh_v10_i10_761 crossref_primary_10_4103_IJCA_IJCA_61_19 crossref_primary_10_1007_s40675_018_0130_7 crossref_primary_10_1016_j_recesp_2018_05_001 crossref_primary_10_1111_jce_14878 crossref_primary_10_1016_j_ijcard_2019_04_061 crossref_primary_10_15420_ecr_2018_32_2 crossref_primary_10_1111_joic_12531 crossref_primary_10_1177_0268355521994997 crossref_primary_10_1093_cvr_cvab017 crossref_primary_10_1007_s40620_020_00720_5 crossref_primary_10_1016_S1474_4422_17_30016_9 crossref_primary_10_3389_fcvm_2024_1303540 crossref_primary_10_1177_1474515117733731 crossref_primary_10_1007_s11886_018_1033_4 crossref_primary_10_1111_jocs_16248 crossref_primary_10_1111_jce_13454 crossref_primary_10_3389_fphys_2018_01221 crossref_primary_10_1016_j_echo_2021_01_004 crossref_primary_10_1016_j_irbm_2022_04_008 crossref_primary_10_1017_cjn_2022_25 crossref_primary_10_1007_s00059_019_4828_1 crossref_primary_10_7759_cureus_45958 crossref_primary_10_1007_s00399_017_0484_4 crossref_primary_10_1016_j_hroo_2024_07_016 crossref_primary_10_1016_j_ultrasmedbio_2017_06_019 crossref_primary_10_1016_j_nmd_2021_01_002 crossref_primary_10_18087_cardio_2019_10_n612 crossref_primary_10_1016_j_ijcha_2024_101372 crossref_primary_10_3238_arztebl_m2021_0150 crossref_primary_10_1016_j_ijcrp_2024_200249 crossref_primary_10_1111_pace_13272 crossref_primary_10_1111_anec_12951 crossref_primary_10_1080_07853890_2021_1875499 crossref_primary_10_1093_ageing_afw104 crossref_primary_10_1016_j_numecd_2018_02_008 crossref_primary_10_1111_joim_12902 crossref_primary_10_1155_2017_2163610 crossref_primary_10_1016_j_compbiomed_2019_103386 crossref_primary_10_1111_jce_14775 crossref_primary_10_3389_fphys_2018_01211 crossref_primary_10_1016_j_cmpb_2016_04_009 crossref_primary_10_3389_fcvm_2020_00003 crossref_primary_10_3389_fcvm_2021_730453 crossref_primary_10_1093_europace_euad185 crossref_primary_10_3389_fphar_2024_1435545 crossref_primary_10_1093_europace_eux127 crossref_primary_10_35440_hutfd_1127431 crossref_primary_10_1063_1_4999611 crossref_primary_10_1016_j_jjcc_2018_06_005 crossref_primary_10_1080_13696998_2024_2399438 crossref_primary_10_1016_j_ijcha_2019_100423 crossref_primary_10_17343_sdutfd_1206357 crossref_primary_10_1136_bmjopen_2017_020282 crossref_primary_10_1136_bmjopen_2017_021121 crossref_primary_10_1093_eurheartj_ehaa1084 crossref_primary_10_1097_01_JAA_0000769672_18363_3f crossref_primary_10_1080_23808993_2020_1735935 crossref_primary_10_33590_emjcardiol_10310292 crossref_primary_10_1002_clc_22895 crossref_primary_10_1080_14737167_2024_2377663 crossref_primary_10_1186_s42444_022_00064_0 crossref_primary_10_7717_peerj_3537 crossref_primary_10_1016_j_ijcard_2018_02_075 crossref_primary_10_3389_fcvm_2020_00132 crossref_primary_10_1016_j_jcin_2019_08_054 crossref_primary_10_1080_00015385_2020_1799573 crossref_primary_10_1111_echo_15572 crossref_primary_10_1007_s00392_021_01959_z crossref_primary_10_1159_000536585 crossref_primary_10_1177_1747493019897870 crossref_primary_10_1007_s00394_019_01952_3 crossref_primary_10_3389_fneur_2023_1123518 crossref_primary_10_1093_cvr_cvaa258 crossref_primary_10_1111_ijcp_13434 crossref_primary_10_2196_29408 crossref_primary_10_1080_00365521_2023_2239973 crossref_primary_10_1016_j_bspc_2021_102500 crossref_primary_10_4244_EIJ_D_24_00100 crossref_primary_10_1038_s41598_020_77562_5 crossref_primary_10_3389_fcvm_2022_879984 crossref_primary_10_2139_ssrn_4097521 crossref_primary_10_4103_ATMR_ATMR_209_24 crossref_primary_10_1007_s12350_018_01480_3 crossref_primary_10_1016_j_jamda_2018_04_017 crossref_primary_10_1136_heartjnl_2024_323950 crossref_primary_10_1038_s41397_017_0007_z crossref_primary_10_1093_europace_euw295 crossref_primary_10_12968_bjca_2017_12_6_265 crossref_primary_10_1038_s41746_019_0207_9 crossref_primary_10_1093_eurpub_cky075 crossref_primary_10_1017_S1463423619000355 crossref_primary_10_1016_j_ejim_2019_04_024 crossref_primary_10_1080_14656566_2020_1789099 crossref_primary_10_1111_jce_15768 crossref_primary_10_1016_j_amjcard_2018_05_015 crossref_primary_10_1097_FJC_0000000000000703 crossref_primary_10_1088_2057_1976_ab1104 crossref_primary_10_1055_s_0041_1735809 crossref_primary_10_31083_j_rcm2308272 crossref_primary_10_1002_ccd_29791 crossref_primary_10_1186_s43044_025_00605_7 crossref_primary_10_1371_journal_pone_0170974 crossref_primary_10_1080_07853890_2023_2193426 crossref_primary_10_1016_j_ultrasmedbio_2016_11_017 crossref_primary_10_1016_j_arr_2020_101092 crossref_primary_10_1556_2066_2021_00048 crossref_primary_10_1002_clc_22677 crossref_primary_10_1007_s40520_022_02107_x |
ContentType | Journal Article |
Copyright | COPYRIGHT 2014 Dove Medical Press Limited 2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2014 Zoni-Berisso et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 |
Copyright_xml | – notice: COPYRIGHT 2014 Dove Medical Press Limited – notice: 2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2014 Zoni-Berisso et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 |
DBID | AAYXX CITATION NPM 3V. 7XB 8C1 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.2147/CLEP.S47385 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) Public Health Database ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Public Health Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Central Health Research Premium Collection ProQuest One Academic UKI Edition ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1179-1349 |
EndPage | 220 |
ExternalDocumentID | oai_doaj_org_article_9e1fbff394134463934fbf2f5e5b48cc PMC4064952 A400253691 24966695 10_2147_CLEP_S47385 |
Genre | Journal Article Review |
GeographicLocations | Italy United States--US Europe Iceland Germany |
GeographicLocations_xml | – name: Italy – name: Iceland – name: Germany – name: United States--US – name: Europe |
GroupedDBID | --- 0YH 29B 2WC 53G 5VS 8C1 8G5 AAYXX ABUWG ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ C1A CCPQU CITATION DIK DWQXO E3Z EBD FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HYE IAO IHR IHW IPNFZ ITC KQ8 M2O M48 M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RIG RPM TDBHL TR2 UKHRP VDV NPM PMFND 3V. 7XB 8FK MBDVC PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c569t-c20a170934474fff1480aa174873842e9d0d67d788b82b926e0cea04a2929adf3 |
IEDL.DBID | M48 |
ISSN | 1179-1349 |
IngestDate | Wed Aug 27 01:24:28 EDT 2025 Thu Aug 21 18:10:27 EDT 2025 Thu Jul 10 18:55:23 EDT 2025 Fri Jul 25 06:03:55 EDT 2025 Tue Jun 17 21:40:51 EDT 2025 Tue Jun 10 20:27:28 EDT 2025 Thu May 22 21:18:48 EDT 2025 Thu Apr 03 07:04:40 EDT 2025 Tue Jul 01 02:28:38 EDT 2025 Thu Apr 24 23:03:15 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | default |
Keywords | mortality epidemiology atrial fibrillation risk factors stroke |
Language | English |
License | http://creativecommons.org/licenses/by-nc/3.0 The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c569t-c20a170934474fff1480aa174873842e9d0d67d788b82b926e0cea04a2929adf3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2224438541?pq-origsite=%requestingapplication% |
PMID | 24966695 |
PQID | 2224438541 |
PQPubID | 3933188 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_9e1fbff394134463934fbf2f5e5b48cc pubmedcentral_primary_oai_pubmedcentral_nih_gov_4064952 proquest_miscellaneous_1541383505 proquest_journals_2224438541 gale_infotracmisc_A400253691 gale_infotracacademiconefile_A400253691 gale_healthsolutions_A400253691 pubmed_primary_24966695 crossref_citationtrail_10_2147_CLEP_S47385 crossref_primary_10_2147_CLEP_S47385 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-01-01 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – month: 01 year: 2014 text: 2014-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New Zealand |
PublicationPlace_xml | – name: New Zealand – name: Macclesfield |
PublicationTitle | Clinical epidemiology |
PublicationTitleAlternate | Clin Epidemiol |
PublicationYear | 2014 |
Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove Medical Press |
References | 16204266 - Eur Heart J. 2005 Nov;26(22):2422-34 11343485 - JAMA. 2001 May 9;285(18):2370-5 12771006 - Circulation. 2003 Jun 17;107(23):2920-5 15864238 - Am Heart J. 2005 Mar;149(3):489-96 21551478 - Europace. 2011 Aug;13(8):1110-7 23321349 - Eur Heart J. 2013 Apr;34(14):1061-7 23220354 - Europace. 2013 Apr;15(4):486-93 19153087 - Europace. 2009 Apr;11(4):423-34 17277353 - Heart. 2007 May;93(5):606-12 22795403 - Int J Cardiol. 2013 Sep 10;167(6):2682-7 22235070 - Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93 16253649 - Prog Cardiovasc Dis. 2005 Sep-Oct;48(2):79-87 15119503 - Ital Heart J. 2004 Mar;5(3):205-13 23266657 - JAMA Intern Med. 2013 Jan 28;173(2):159-60 22514252 - Circulation. 2012 May 15;125(19):2298-307 24345399 - Circulation. 2014 Feb 25;129(8):837-47 24360776 - Am J Cardiol. 2014 Feb 15;113(4):655-61 16987906 - Europace. 2006 Sep;8(9):651-745 21920917 - Circ Heart Fail. 2011 Nov;4(6):740-6 9040682 - Stroke. 1997 Feb;28(2):316-21 19176537 - Eur Heart J. 2010 Apr;31(8):967-75 1866765 - Stroke. 1991 Aug;22(8):983-8 21610240 - JAMA. 2011 May 25;305(20):2080-7 23273528 - Am J Cardiol. 2013 Mar 1;111(5):705-11 17548732 - Circulation. 2007 Jun 19;115(24):3050-6 20170808 - J Am Coll Cardiol. 2010 Feb 23;55(8):725-31 22949543 - Circulation. 2012 Sep 4;126(10):e143-6 7062992 - N Engl J Med. 1982 Apr 29;306(17):1018-22 23478104 - Am J Emerg Med. 2013 May;31(5):792-7 22361078 - Circ Heart Fail. 2012 Mar 1;5(2):191-201 24119623 - J Stroke Cerebrovasc Dis. 2014 Feb;23 (2):e73-83 22787011 - Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):632-9 17336723 - J Am Coll Cardiol. 2007 Mar 6;49(9):986-92 24774588 - Rev Esp Cardiol (Engl Ed). 2014 Apr;67(4):259-69 23900699 - Eur Heart J. 2013 Sep;34(35):2746-51 16818816 - Circulation. 2006 Jul 11;114(2):119-25 23879838 - J Intern Med. 2013 Nov;274(5):461-8 15851136 - Heart Rhythm. 2004 Jul;1(2 Suppl):B31-4, discussion B34-5 24236932 - Pacing Clin Electrophysiol. 2014 Mar;37(3):345-55 18397874 - Eur Heart J. 2008 May;29(9):1181-9 23393083 - Heart. 2013 Aug;99(16):1166-72 17673732 - BMJ. 2007 Aug 25;335(7616):383 19433768 - Circulation. 2009 May 12;119(18):2516-25 21533828 - Clin Res Cardiol. 2011 Oct;100(10):897-905 22884698 - Int J Cardiol. 2013 Sep 10;167(6):2895-903 10368121 - Circulation. 1999 Jun 15;99(23):3028-35 |
References_xml | – reference: 11343485 - JAMA. 2001 May 9;285(18):2370-5 – reference: 24345399 - Circulation. 2014 Feb 25;129(8):837-47 – reference: 23900699 - Eur Heart J. 2013 Sep;34(35):2746-51 – reference: 23478104 - Am J Emerg Med. 2013 May;31(5):792-7 – reference: 19153087 - Europace. 2009 Apr;11(4):423-34 – reference: 15851136 - Heart Rhythm. 2004 Jul;1(2 Suppl):B31-4, discussion B34-5 – reference: 21610240 - JAMA. 2011 May 25;305(20):2080-7 – reference: 22514252 - Circulation. 2012 May 15;125(19):2298-307 – reference: 16818816 - Circulation. 2006 Jul 11;114(2):119-25 – reference: 16204266 - Eur Heart J. 2005 Nov;26(22):2422-34 – reference: 23220354 - Europace. 2013 Apr;15(4):486-93 – reference: 17277353 - Heart. 2007 May;93(5):606-12 – reference: 16987906 - Europace. 2006 Sep;8(9):651-745 – reference: 24774588 - Rev Esp Cardiol (Engl Ed). 2014 Apr;67(4):259-69 – reference: 12771006 - Circulation. 2003 Jun 17;107(23):2920-5 – reference: 23321349 - Eur Heart J. 2013 Apr;34(14):1061-7 – reference: 22884698 - Int J Cardiol. 2013 Sep 10;167(6):2895-903 – reference: 15864238 - Am Heart J. 2005 Mar;149(3):489-96 – reference: 24360776 - Am J Cardiol. 2014 Feb 15;113(4):655-61 – reference: 20170808 - J Am Coll Cardiol. 2010 Feb 23;55(8):725-31 – reference: 23273528 - Am J Cardiol. 2013 Mar 1;111(5):705-11 – reference: 22235070 - Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93 – reference: 24119623 - J Stroke Cerebrovasc Dis. 2014 Feb;23 (2):e73-83 – reference: 15119503 - Ital Heart J. 2004 Mar;5(3):205-13 – reference: 24236932 - Pacing Clin Electrophysiol. 2014 Mar;37(3):345-55 – reference: 23393083 - Heart. 2013 Aug;99(16):1166-72 – reference: 1866765 - Stroke. 1991 Aug;22(8):983-8 – reference: 17336723 - J Am Coll Cardiol. 2007 Mar 6;49(9):986-92 – reference: 19433768 - Circulation. 2009 May 12;119(18):2516-25 – reference: 9040682 - Stroke. 1997 Feb;28(2):316-21 – reference: 18397874 - Eur Heart J. 2008 May;29(9):1181-9 – reference: 16253649 - Prog Cardiovasc Dis. 2005 Sep-Oct;48(2):79-87 – reference: 23879838 - J Intern Med. 2013 Nov;274(5):461-8 – reference: 22361078 - Circ Heart Fail. 2012 Mar 1;5(2):191-201 – reference: 10368121 - Circulation. 1999 Jun 15;99(23):3028-35 – reference: 21920917 - Circ Heart Fail. 2011 Nov;4(6):740-6 – reference: 19176537 - Eur Heart J. 2010 Apr;31(8):967-75 – reference: 22795403 - Int J Cardiol. 2013 Sep 10;167(6):2682-7 – reference: 21533828 - Clin Res Cardiol. 2011 Oct;100(10):897-905 – reference: 7062992 - N Engl J Med. 1982 Apr 29;306(17):1018-22 – reference: 17673732 - BMJ. 2007 Aug 25;335(7616):383 – reference: 23266657 - JAMA Intern Med. 2013 Jan 28;173(2):159-60 – reference: 17548732 - Circulation. 2007 Jun 19;115(24):3050-6 – reference: 22949543 - Circulation. 2012 Sep 4;126(10):e143-6 – reference: 21551478 - Europace. 2011 Aug;13(8):1110-7 – reference: 22787011 - Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):632-9 |
SSID | ssj0000331770 |
Score | 2.5536616 |
SecondaryResourceType | review_article |
Snippet | In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care... Massimo Zoni-Berisso, Fabrizio Lercari, Tiziana Carazza, Stefano DomenicucciDepartment of Cardiology, ASL 3, Padre A Micone Hospital, Genoa, ItalyAbstract: In... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 213 |
SubjectTerms | Acute coronary syndromes Anticoagulants Atrial fibrillation Cardiac arrhythmia Clinical medicine Comorbidity Complications and side effects Epidemiology Health care policy Heart failure Males Mortality Older people Population Public health Review Risk factors Stroke Studies Trends Womens health |
SummonAdditionalLinks | – databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dS8MwEA_ikyDit_OzgiAI1bbJ0sa3KRsiIoIKvoUkTVAY3XDzwf_eu6SrKwq--LjebTS3u-R-4e53hJyw3CIPmAGQY4qYCa1jZUoalzy3Qlma56Ha4p7fPLPbl-7L3KgvrAkL9MDBcBfCpk47RwXstgBdqKAMPmeua7uaFcbg7gtn3hyY8nswhXPRT4pDyrMYOfhCcx6O5bmA3x2fTxgSubSOI8_a_3Nvnjuc2oWTcyfRYJWs1Clk1AuvvkYWbLVOlsP9WxTaijaI6H-Pfv2MRi5Sfj5H5LDEfxgK4C6j2V18NP7uudwkz4P-0_VNXI9JiE2Xi2lsskSleSKQu4855wDgJAqeABShBcusKBOwfAlYVxeZFhm3ibEqYSqD1EiVjm6RxWpU2R0SlYlTlHNdckOZgeh0hbKYAyrFs1TzDjmbWUuamkMcR1kMJWAJNK28vus_yEdv2g45aZTHgTrjd7UrNHujgnzX_gF4gay9QP7lBR1yhH-aDM2jTdTKHsOkjnKRdsip18C4hVc2qm4_gIUjA1ZLc7-lCfFm2uKZY8g63icSsizGYDEMxMeNGL-JNWyVHX1MJCSrKYWEN4Elbwc_ahYNIBhwpABJ3vKwllXakurt1bOBQ0YGIDfb_Q8z7pElSAhZuGLaJ4vT9w97AEnXVB_6-PoC3iAnxw priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS90wFA9OXwZjbLqP-tmBMBh0pk2aNnsRlSsiQ8RN8C0kabINpL3zXh_87z2nye21bPjY5BSak5yc8zs9H4Ts88phHTALIMfWGZfGZNo2LGtE5aR2rKpCtMWFOLvm5zflTXS4zWJY5eJO7C_qprPoIz8APcY5q0ueH07_Ztg1Cv-uxhYaL8gaXME1gK-148nF5dXgZaEM9GNFQ2IetuQ5OPk-ufz6g2MRl5Eq6iv2_3svP1FM46DJJ1ro9A15Hc3H9Cjs91uy4tp18ir43tKQUrRB5GTZ9vUh7Xyq-94cqcfw_tsQ_PYtXfjh0-ky3_IduT6d_Dw5y2KLhMyWQs4zW1CdV1Ri3T7uvQdwQzWMAAxhNS-cbChwvQGca-rCyEI4ap2mXBdgFunGs_dkte1a95GkDfWaCWEaYRm3IJm-1g7tP61FkRuRkC8Lbikb64djG4tbBTgCWauQtSqwNiH7A_E0lM34P9kxsn0gwVrX_UB390tF0VHS5d54zyToWwCvDBYLz4UvXWl4bW1C9nDTVEgcHSRWHXE06JiQeUI-9xQos_DJVsfUA1g4Vr8aUW6PKEHW7Hh6cTBUlPWZWp7MhHwapvFNjF9rXXc_U2Co5gyMXQpL_hDO0bBoAMCAISXMVKMTNuLKeKb987uvBA7WGADcYvP5z9oiL8HM48FxtE1W53f3bgdMqbnZjfLyCOjAHYk priority: 102 providerName: ProQuest |
Title | Epidemiology of atrial fibrillation: European perspective |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24966695 https://www.proquest.com/docview/2224438541 https://www.proquest.com/docview/1541383505 https://pubmed.ncbi.nlm.nih.gov/PMC4064952 https://doaj.org/article/9e1fbff394134463934fbf2f5e5b48cc |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1ta9RAEB768kUQ8d1oPSMUBCF1k93bZAWR9rhyiJaiHtRPy2azq8KRq9cr2H_vTDZJL1q_HFx2ctxMZjLPLLPPAOyL3BEPmMUixxaJUGWZGFvxpJK5U8bxPA_dFidyNhcfzsZnW9AN42wNeHFjaUfzpOarxcHvX1fvMeDfURtzKvI3k4_T04MvgnhZtmEXU1JOEfqpxfnNK5ljmmwGxxEDWkKUfOGs3t_3EzewwApA0ryJjUTV8Pn_-9beSFvDlsqNHHV8F-604DI-DN5wD7ZcfR9uh525OBw4egBqej0U9ipe-tg0kztiT83_i9Aa9zbudunj8-vTmA9hfjz9Opkl7QCFxI6lWic2YybNmSJWP-G9x9KHGbyCRQovROZUxfCZVFgFl0VWqkw6Zp1hwmQImkzl-SPYqZe1ewJxxbzhUpaVtFxYjFtfGEfo0BiZpaWM4HVnLW1bdnEacrHQWGWQlTVZWQcrR7DfC58HUo2bxY7I7L0IMWE3F5ar77oNLK1c6kvvucJsjKUtR2Xxe-bHblyKwtoIXtBD0-FYaR_P-lAQ3ONSpRG8aiTIx_AvW9MeTEDFiRtrILk3kMRItMPlzjF058ga8ZcQqIzA5Zf9Mt1J3W21W15eaISxKUcozFDlx8GPeqU7d4wgH3jYwCrDlfrnj4YnHLEalr_Z0__-5jO4hfhPhB2lPdhZry7dc8RY63IE2-zbDD-LSTqC3aPpyennUbNfMWoi6w9znyRa |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-N7gGkCfG9wGBBGkJCypbYjhMjIbSNTh0r1QSbtDfjODYgTU1ZO6H9U_yNnOMkXQTibY-Nr5V9Od_d73ofAFssM64PmEaQo_OIiaKIlC5pVPLMCGVolvlsiwkfnbKPZ-nZCvxua2FcWmWrE2tFXVbaxch30I4xRvOUJe9nPyM3Ncr9u9qO0PBicWSufiFkm787_IDv9xUhB8OT_VHUTBWIdMrFItIkVkmGQJ6xjFlrEQ_ECp-g505zRowoY9xoidCwyEkhCDexNipmiqAnoUpL8XdvwSqjCGUGsLo3nBx_7qI6MUV7nMW-ENCNANrZHw-Pt78w1zSmZ_rqCQF_24FrhrCfpHnN6h3cg7uNuxruevm6Dytm-gDWfKwv9CVMD0EMl2Nmr8LKhqqeBRJaV05w7pPt3oZt3D-cLes7H8HpjTDvMQym1dSsQ1jGVlHOi5JryjRqApsr4_xNpThJCh7Am5ZbUjf9yt3YjHOJuMWxVjrWSs_aALY64plv0_Fvsj3H9o7E9dauH1QX32RzVaUwiS2spQLtO4JliofFz8SmJi1YrnUAm-6lSV-o2mkIucucA0m5SAJ4XVM4HYFb1qopdcCDu25bPcqNHiXebd1fbgVDNrplLpc3IYCX3bL7psuXm5rqci7RMU4oOtcxHvmJl6Pu0Ai4EbMKXMl6EtbjSn9l-uN73XkcvT8E1OTp_7e1CbdHJ5_Gcnw4OXoGd9DFZD5otQGDxcWleY5u3KJ40dydEL7e9HX9Az-KWSg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ta9RAEB5qBRFEfPe02ggVQYiXZDebrCBSr3e0tpSCFvptu9nsqlCSs3dF-tf8dc5kk1yD4rd-THYSdic7L89mXgC2eGapDphBkGPykMuiCLUpWViKzEptWZb5aItDsXvMP5-kJ2vwu8uFobDKTic2irqsDZ2Rj9GOcc7ylMdj14ZFHO3MPs5_htRBiv60du00_BbZt5e_EL4tPuzt4Ld-nSSz6dfJbth2GAhNKuQyNEmk4wxBPecZd84hNog03kEvnuU8sbKMcNIlwsQiTwqZCBsZqyOuE_QqdOkYvvcG3MwY2lnKUp_E_flOxNAyZ5FPCaRmQOPJwfTo3RdO5WMGRrDpFfC3RbhiEofhmlfs3-we3G0d12Db77T7sGarB3DHn_oFPpnpIcjpquHsZVC7QDddQQJHiQVnPuzufdD9AQjmq0zPR3B8Lax7DOtVXdmnEJSR00yIohSGcYM6weXakueptUjiQozgbcctZdrK5dRA40whgiHWKmKt8qwdwVZPPPcFO_5N9onY3pNQle3mRn3-TbVCq6SNXeEck2jpETYzXCxeJy61acFzY0awSR9N-ZTVXleobU6uJBMyHsGbhoK0BU7Z6DbpARdOdbcGlBsDSpRyMxzuNoZqtcxCrWRiBK_6YXqSIucqW18sFLrIMUM3O8IlP_H7qF80Qm9ErxJHssEOG3BlOFL9-N7UIEc_EKF18uz_09qEWyik6mDvcP853EZfk_vTqw1YX55f2Bfozy2Ll43gBHB63ZL6BzoxW8w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+of+atrial+fibrillation%3A+European+perspective&rft.jtitle=Clinical+epidemiology&rft.au=Zoni-Berisso%2C+Massimo&rft.au=Lercari%2C+Fabrizio&rft.au=Carazza%2C+Tiziana&rft.au=Domenicucci%2C+Stefano&rft.date=2014-01-01&rft.issn=1179-1349&rft.eissn=1179-1349&rft.volume=6&rft.spage=213&rft_id=info:doi/10.2147%2FCLEP.S47385&rft_id=info%3Apmid%2F24966695&rft.externalDocID=24966695 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1179-1349&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1179-1349&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1179-1349&client=summon |